Monday, October 10, 2016

Biologic agents may increase infection risk in inflammatory bowel disease : clinicaladvisor





as declared in clinicaladvisor

Biologic agents may increase infection risk in inflammatory bowel disease

Biologic agents may increase infection risk in inflammatory bowel disease
Biologic agents may increase infection risk in inflammatory bowel disease
Biologic agents may increase infection risk in inflammatory bowel diseaseShare this content:linkedingooglePrintBiologic agents increase the risk of opportunistic infection, but do not increase the risk of serious infection or malignancy.HealthDay News — For adults with inflammatory bowel disease (IBD), biologic agents increase the risk of infection, especially opportunistic infection, but do not increase the risk of serious infection or malignancy, according to a review published in the October issue of Clinical Gastroenterology and Hepatology.Stefanos Bonovas, MD, PhD, from Humanitas Clinical and Research Center in Milan, and colleagues performed a systematic review and meta-analysis to examine whether biologic agents impact the risk of infection or malignancy in adults with IBD.


in addition washingtonpost

Did his artificial hips put him at risk of infection when he saw the dentist?

Did his artificial hips put him at risk of infection when he saw the dentist?
Did his artificial hips put him at risk of infection when he saw the dentist?
People with replacement joints have long been told to take antibiotics before having even routine dental treatment.But that advice isn't as widely supported as it once was.(Edward Olive/Getty Images/iStock)Joint replacement is among the most reliable of common surgeries.


in addition news-medical

Study provides new insights into Zika's rapid infection and risk for transmission

Study provides new insights into Zika's rapid infection and risk for transmission
Study provides new insights into Zika's rapid infection and risk for transmission
Though first documented 70 years ago, the Zika virus was poorly understood when it burst onto the scene in the Americas in 2015.In one of the first and largest studies of its kind, a research team lead by virologists at Beth Israel Deaconess Medical Center (BIDMC) has characterized the progression of two strains of the viral infection.The study, published online this week in Nature Medicine, revealed Zika's rapid infection of the brain and nervous tissues, and provided evidence of risk for person-to-person transmission.


Study provides new insights into Zika's rapid infection and risk for transmission

No comments:

Post a Comment